Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

Pre-capillary pulmonary hypertension (PH) in systemic sclerosis (SSc) is a heterogeneous condition with an overall bad prognosis. The objective of this study was to identify and characterize homogeneous phenotypes by a cluster analysis in SSc patients with PH. Patients were identified from two prosp...

Full description

Bibliographic Details
Main Authors: David Launay, David Montani, Paul M Hassoun, Vincent Cottin, Jérôme Le Pavec, Pierre Clerson, Olivier Sitbon, Xavier Jaïs, Laurent Savale, Jason Weatherald, Vincent Sobanski, Stephen C Mathai, Majid Shafiq, Jean-François Cordier, Eric Hachulla, Gérald Simonneau, Marc Humbert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5953495?pdf=render
id doaj-a93828610ff445e38a16384e33cba245
record_format Article
spelling doaj-a93828610ff445e38a16384e33cba2452020-11-24T20:41:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01135e019711210.1371/journal.pone.0197112Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.David LaunayDavid MontaniPaul M HassounVincent CottinJérôme Le PavecPierre ClersonOlivier SitbonXavier JaïsLaurent SavaleJason WeatheraldVincent SobanskiStephen C MathaiMajid ShafiqJean-François CordierEric HachullaGérald SimonneauMarc HumbertPre-capillary pulmonary hypertension (PH) in systemic sclerosis (SSc) is a heterogeneous condition with an overall bad prognosis. The objective of this study was to identify and characterize homogeneous phenotypes by a cluster analysis in SSc patients with PH. Patients were identified from two prospective cohorts from the US and France. Clinical, pulmonary function, high-resolution chest tomography, hemodynamic and survival data were extracted. We performed cluster analysis using the k-means method and compared survival between clusters using Cox regression analysis. Cluster analysis of 200 patients identified four homogenous phenotypes. Cluster C1 included patients with mild to moderate risk pulmonary arterial hypertension (PAH) with limited or no interstitial lung disease (ILD) and low DLCO with a 3-year survival of 81.5% (95% CI: 71.4-88.2). C2 had pre-capillary PH due to extensive ILD and worse 3-year survival compared to C1 (adjusted hazard ratio [HR] 3.14; 95% CI 1.66-5.94; p = 0.0004). C3 had severe PAH and a trend towards worse survival (HR 2.53; 95% CI 0.99-6.49; p = 0.052). Cluster C4 and C1 were similar with no difference in survival (HR 0.65; 95% CI 0.19-2.27, p = 0.507) but with a higher DLCO in C4. PH in SSc can be characterized into distinct clusters that differ in prognosis.http://europepmc.org/articles/PMC5953495?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author David Launay
David Montani
Paul M Hassoun
Vincent Cottin
Jérôme Le Pavec
Pierre Clerson
Olivier Sitbon
Xavier Jaïs
Laurent Savale
Jason Weatherald
Vincent Sobanski
Stephen C Mathai
Majid Shafiq
Jean-François Cordier
Eric Hachulla
Gérald Simonneau
Marc Humbert
spellingShingle David Launay
David Montani
Paul M Hassoun
Vincent Cottin
Jérôme Le Pavec
Pierre Clerson
Olivier Sitbon
Xavier Jaïs
Laurent Savale
Jason Weatherald
Vincent Sobanski
Stephen C Mathai
Majid Shafiq
Jean-François Cordier
Eric Hachulla
Gérald Simonneau
Marc Humbert
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
PLoS ONE
author_facet David Launay
David Montani
Paul M Hassoun
Vincent Cottin
Jérôme Le Pavec
Pierre Clerson
Olivier Sitbon
Xavier Jaïs
Laurent Savale
Jason Weatherald
Vincent Sobanski
Stephen C Mathai
Majid Shafiq
Jean-François Cordier
Eric Hachulla
Gérald Simonneau
Marc Humbert
author_sort David Launay
title Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
title_short Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
title_full Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
title_fullStr Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
title_full_unstemmed Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
title_sort clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description Pre-capillary pulmonary hypertension (PH) in systemic sclerosis (SSc) is a heterogeneous condition with an overall bad prognosis. The objective of this study was to identify and characterize homogeneous phenotypes by a cluster analysis in SSc patients with PH. Patients were identified from two prospective cohorts from the US and France. Clinical, pulmonary function, high-resolution chest tomography, hemodynamic and survival data were extracted. We performed cluster analysis using the k-means method and compared survival between clusters using Cox regression analysis. Cluster analysis of 200 patients identified four homogenous phenotypes. Cluster C1 included patients with mild to moderate risk pulmonary arterial hypertension (PAH) with limited or no interstitial lung disease (ILD) and low DLCO with a 3-year survival of 81.5% (95% CI: 71.4-88.2). C2 had pre-capillary PH due to extensive ILD and worse 3-year survival compared to C1 (adjusted hazard ratio [HR] 3.14; 95% CI 1.66-5.94; p = 0.0004). C3 had severe PAH and a trend towards worse survival (HR 2.53; 95% CI 0.99-6.49; p = 0.052). Cluster C4 and C1 were similar with no difference in survival (HR 0.65; 95% CI 0.19-2.27, p = 0.507) but with a higher DLCO in C4. PH in SSc can be characterized into distinct clusters that differ in prognosis.
url http://europepmc.org/articles/PMC5953495?pdf=render
work_keys_str_mv AT davidlaunay clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT davidmontani clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT paulmhassoun clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT vincentcottin clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT jeromelepavec clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT pierreclerson clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT oliviersitbon clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT xavierjais clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT laurentsavale clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT jasonweatherald clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT vincentsobanski clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT stephencmathai clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT majidshafiq clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT jeanfrancoiscordier clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT erichachulla clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT geraldsimonneau clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
AT marchumbert clinicalphenotypesandsurvivalofprecapillarypulmonaryhypertensioninsystemicsclerosis
_version_ 1716824460360679424